Product Datasheet
|
|
| |
| Product Description |
| |
| Product: |
Apolipoprotein C3, Human Plasma, VLDL |
| Catalog Number: |
HAPO-C3 |
| Product Page: |
https://www.mol-innov.com/products/ |
| Description: |
Apo CIII inhibits the activation of lipoprotein lipase by Apo CII. Reduced levels of Apo CIII result in higher fatty acid uptake from plasma triglycerides into adipose tissue. Thus, Apo CIII is a potential target for treatment of obesity and insulin resistance. The normal plasma concentration of Apo CIII is 8-15 mg per 100 ml. Prepared from fresh, non-frozen plasma shown to be non reactive for HbsAG, anti-HCV, anti-HBc, and negative for anti-HIV 1 & 2 by FDA approved tests. >95percent pure by SDS-PAGE. |
| Recommended Storage: |
SAMPLE |
| Minimum Shelf Life: |
308.75 |
| Source: |
1.0 mg/ml |
| Molecular Weight: |
Proteins |
| Extinction Coefficient: |
8,750 |
| Antigen: |
-70 C |
| Target: |
Frozen liquid |
| Target Molecular Weight: |
HUMAN PLASMA PROTEINS |
| Host: |
536.75 |
| Clonality: |
5 |
| Isotype: |
Human plasma |
| Clone: |
s |
| Applications: |
Dry ice |
| Cross-reactivity: |
3 years from delivery |
| Concentration: |
325 |
| Volume: |
565 |
| Titer: |
0.01M Ammonium Bicarbonate; pH 7.4 |
| Buffer: |
SAMPLE |
| Form: |
0.1 mg |
| Preservative: |
0.1 ml |
| |
| Optimal experimental conditions and working dilutions must be determined by the end user. Sample concentration and volume are for example purposes only and do not necessarily represent the product that will be received. Please contact us for a current lot-specific product datasheet. |
| |
| For in vitro laboratory use only |
| |
Molecular Innovations, Inc. - 46430 Peary Court, Novi, MI 48377, USA
Tel: (888) 557-5055 - Fax: (248) 896-0148 - info@mol-innov.com |